News
![Sir Stephen O’Rahilly](https://pharmaphorum.com/wp-content/uploads/2018/08/Sir-Stephen-O’Rahilly.jpg)
The first lipodystrophy treatment for European patients
Novelion Therapeutics’ Myalepta (metreleptin) developed for the ultra-rare condition lipodystrophy has been approved by the European Commission, giving patients the first treatment to impro